Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjian Mo

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
BMC Medicine|March 27, 2024
A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in ChinaYing Wang, Depei Wu, Xiang Zhang, et al.
European Journal of Medical Research|January 20, 2026
Refining letermovir prophylaxis strategies and CD4 + T cell-guided discontinuation in aplastic anemia patients post-allogeneic HSCT: a retrospective analysisYuling Zhang, Xiaoqing He, Ming Zhou, et al.
International Immunopharmacology|January 7, 2025
IFN alpha signaling drives hematopoietic stem cells malfunction under acute inflammationXue Han, Minyi Zhao, Kexin Wang, et al.
Blood Advances|August 27, 2021
Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantationXiying Ren, Qiusha Huang, Qingyuan Qu, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
BMC Medicine|March 27, 2024
A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in ChinaYing Wang, Depei Wu, Xiang Zhang, et al.
European Journal of Medical Research|January 20, 2026
Refining letermovir prophylaxis strategies and CD4 + T cell-guided discontinuation in aplastic anemia patients post-allogeneic HSCT: a retrospective analysisYuling Zhang, Xiaoqing He, Ming Zhou, et al.
International Immunopharmacology|January 7, 2025
IFN alpha signaling drives hematopoietic stem cells malfunction under acute inflammationXue Han, Minyi Zhao, Kexin Wang, et al.
Blood Advances|August 27, 2021
Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantationXiying Ren, Qiusha Huang, Qingyuan Qu, et al.
Pageof 5